Drew Deathe

Drew Deathe, MPH, is currently a Manager of Clinical Development in Cardiometabolic Health at Eli Lilly and Company, where they lead clinical development trials. Previously, Drew served as a Research Portfolio Manager at The Carter Center from 2019 to 2022 and worked as an Epidemiologist at IHRC, Inc. from 2018 to 2019. Drew's early experience includes roles as a Clinical Research Intern at Riley Hospital for Children and a Research Assistant at Indiana University School of Medicine. They earned a Master of Public Health in Global Health & Infectious Disease from Emory University and a Bachelor of Science in Health Sciences from Ball State University.